Joseph C. Wu, Co-Founder and Board Member at Greenstone Biosciences, Director of Stanford Cardiovascular Institute, Simon Stertzer Endowed Professor of Medicine and Radiology at Stanford University School of Medicine shared a post on LinkedIn:
“I’m honored to be the recipient of the 2026 The American Society for Clinical Investigation Stanley J. Korsmeyer Award.
The Stanley J. Korsmeyer award recognizes the outstanding achievements of ASCI members in advancing knowledge in a specific field and in mentoring future generations of life science researchers. The recognition, which was first known as the ASCI Award, was renamed in 2006 in honor of Dr. Stanley J. Korsmeyer, a dedicated and accomplished physician-scientist and mentor who was the first recipient in 1998 and who passed away in 2005. The recipient of the annual Award is provided with a $20,000 honorarium.
Recent past recipients include:
2025: W. Kimryn Rathmell, MD, PhD, for her work in kidney cancer research and leadership.
2024: Howard Y. Chang, MD, PhD, for genome science contributions.
2023: Nicole Calakos, MD, PhD, for research on movement disorders.
2021: Benjamin Ebert, MD, PhD, for contributions to understanding myelodysplastic syndromes.
My Korsmeyer Award Lecture focused on ‘Genomics, AI, and NAMs for Drug Discovery’ and covers the past 20 years of research in which we have advocated for the concept of ‘clinical trial in-a-dish’ (CTiD) using human induced pluripotent stem cells (iPSCs) as patient’s ‘biological twin’, that can be converted into multiomics ‘digital twin’ dataset, that can then be fed into AI/ML softwares for better prediction of drug safety and efficacy, and that can then be tested on disease-specific cell types that we design the drugs for. This closed-loop system allows continuous cycle of monitoring, acting, and reacting to maintain accuracy, as highlighted in these recent review articles:
- Reimagining human-centric drug development with new approach methodologies
- New approach methodologies for drug discovery
- Alternatives to animal testing are the future — it’s time that journals, funders and scientists embrace them
Special thanks to all the mentors and trainees whom I have worked with and trained. And my sincere gratitude to ASCI president Priscilla Hsue, long-time ASCI staff (John Hawley, Karen Guth), Susan Korsmeyer, E. Dale Abel, Tamer Sallam, David Geffen School of Medicine at UCLA STAR program, my late mentor Sanjiv S. Gambhir, Stanford University School of Medicine, Dean Lloyd Minor, Stanford Cardiovascular Institute, Greenstone Biosciences, and many others.”
Other articles featuring Joseph C. Wu on OncoDaily.
